Please provide your email address to receive an email when new articles are posted on . In recent years, we have made significant strides in our understanding of the pathogenesis of asthma. As a ...

In a finding that could have important implications for the millions of Americans who suffer from asthma, researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID) have ...

—Treating increasing asthma severity represents 80% of asthma care costs. So what can be done to bring down exacerbation rates? Biomarkers provide some clues. Reviewed by Ware Kuschner, MD, Professor ...

For patients with moderate to severe asthma, blockade with itepekimab, a new human IgG4P monoclonal antibody against the upstream alarmin interleukin-33, led to a reduction in events that indicate ...

Researchers at the Keck School of Medicine of the University of Southern California have discovered that a protein called Piezo1 prevents type 2 innate lymphoid cells (ILC2s) in the lung from becoming ...

Asthma is a chronic respiratory condition marked by airway inflammation, narrowing, and episodes of wheezing, coughing, and shortness of breath. It affects millions of people worldwide and continues ...

People with severe asthma are more likely to have antibodies against the disease-causing bacteria Chlamydia pneumoniae than the general population and in some cases antibiotic treatment can greatly ...

Allergens? No. Inflammation? No. An over-active gene that interrupts lipid synthesis appears to be the cause of 20-30% childhood asthma cases. Little is known about why asthma develops, how it ...

Predisposing factors (genetic profile, stress, and age), dietary and lifestyle choices, and inflammatory mechanisms all contribute to the hypertensive asthmatic phenotype. These factors may be ...